Harmony Biosciences Holdings, Inc.

Healthcare · Biotechnology · United States

Last price 38.59 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.25B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also develops Pitolisant that is in Phase 3 clinical trial for the treatment of Prader-Willi Syndrome (PWS); in Phase 2 clinical trial to treat Myotonic Dystrophy (DM1); and is in P...